Modulating the Lifetime of DNA Motifs Using Visible Light and Small Molecules
Journal of the American Chemical Society · 2023
DOI: 10.1021/jacs.2c13232 ↗At a glance
Journal article in Journal of the American Chemical Society, 2023. Written by Laura Wimberger and 2 co-authors. Institution: School of Chemistry, UNSW Sydney, Sydney NSW 2052, Australia. Major MEDLINE topics: Nanotechnology, Light. Cited 31 times so far (Crossref); 76 references. Funded by: Australian Research Council.
Abstract (original language)
Here we regulate the formation of dissipative assemblies built from DNA using a merocyanine photoacid that responds to visible light. The operation of our system and the relative distribution of species within it are controlled by irradiation time, initial pH value, and the concentration of a small-molecule binder that inhibits the reaction cycle. This approach is modular, does not require DNA modification, and can be used for several DNA sequences and lengths. Our system design allows for waste-free control of dissipative DNA nanotechnology, toward the generation of nonequilibrium, life-like nanodevices.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- School of Chemistry, UNSW Sydney, Sydney NSW 2052, Australia.
ORCID profiles: Laura Wimberger, Felix J Rizzuto, Jonathon E Beves
Funding
- Australian Research Council
Cite
APA
Wimberger, L., Rizzuto, F. J., & Beves, J. E. (2023). Modulating the Lifetime of DNA Motifs Using Visible Light and Small Molecules. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.2c13232
Vancouver
Wimberger L, Rizzuto FJ, Beves JE. Modulating the Lifetime of DNA Motifs Using Visible Light and Small Molecules. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.2c13232
BibTeX
@article{Wimberger2023,
author = {Wimberger, Laura and Rizzuto, Felix J and Beves, Jonathon E},
title = {Modulating the Lifetime of DNA Motifs Using Visible Light and Small Molecules},
journal = {Journal of the American Chemical Society},
year = {2023},
doi = {10.1021/jacs.2c13232}
}
EUVIMED